Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

4.01
Delayed Data
As of Jun 22
 +0.02 / +0.50%
Today’s Change
2.05
Today|||52-Week Range
8.75
-36.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$191.0M

Company Description

Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel antibiotics for serious and life-threatening bacterial infections. It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.

Contact Information

Tetraphase Pharmaceuticals, Inc.
480 Arsenal Street
Watertown Massachusetts 02472
P:(617) 715-3600
Investor Relations:

Employees

Shareholders

Other institutional25.96%
Individual stakeholders22.28%
Mutual fund holders20.65%

Top Executives

Guy MacDonaldPresident, Chief Executive Officer & Director
Larry EdwardsChief Operating Officer
Christopher WattChief Financial & Accounting Officer
Larry TsaiChief Medical Officer
Jacques DumasChief Scientific Officer